Reistone Biopharma Company Limited is a clinical stage biopharmaceutical company focused on developing novel medicines for immuno-inflammatory diseases with unmet medical needs. Developing therapies for diseases requires new approaches and strong collaboration between scientists, industry, regulatory agencies and patient groups. Reistone is forged from the company's close collaborations with key stakeholders and leading pharmaceutical companies, and is dedicated to transforming new biotechnology insights into breakthrough medicine for significant unmet medical needs in China as well globally.
Our mission is to work together to deliver innovative and accessible medicines to patients in the field of immuno-inflammatory disorders. Our strategy is to harness innovative science to produce the promise of the best medicines. This is inspired by our vision, to be a globally recognized leader committed to bringing the best innovative medicines to the world.
We believe that the key success factor in drug research and development is to combine innovative clinical development strategy/expertise and efficient drug development processes. Our team is built with senior people who have worked in top multinational pharmaceutical companies for a long time and want to make a direct impact for patients around the globe with Reistone.